IP Library Granted Patent US 9,669,211
Granted Patent B2
US 9,669,211 · App. 15/165,414 · Granted Jun 6, 2017

Method and apparatus for applying neuromuscular electrical stimulation

Inventors: Yorick Wijting (Hixson, TN); Jeffrey K. Pohl (Soddy Daisy, TN)
Assignee: Encore Medical Asset Corporation
A61N1/36003A61N1/0452A61N1/36014A61N7/00A61N2007/0026
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,669,211
App. No.
15/165,414
Granted
Jun 6, 2017
Kind
B2
Abstract

A method and apparatus for applying neuromuscular electrical stimulation to an agonist/antagonist muscle pair to move a limb about a joint includes generating a first pattern of neuromuscular electrical stimulation pulses for output through a first channel to a first pair of electrodes and generating a second pattern of neuromuscular stimulation pulses for output through a second channel to a second pair of electrodes. The first pair of electrodes are attached to the agonist muscle of the agonist/antagonist muscle pair, and the second pair of electrodes are attached to the antagonist muscle. A first pattern of electrical stimulation pulses is transmitted through the first pair of electrodes to the agonist muscle at a first intensity level to initiate contraction of the agonist muscle, and then at a second intensity level which is less than the first intensity level to continue contraction of the agonist muscle. A second pattern of electrical stimulation pulses is transmitted through the second pair of electrodes to the antagonist muscle at a first intensity level to reduce the acceleration of the limb, and then at a second intensity level which is less than the first intensity level to regulate the movement of the limb.

Claims (24)

1. A device for applying neuromuscular electrical and ultrasound stimulation to an agonist/antagonist muscle pair to move a limb about a joint, said device comprising a main stimulator controller, an ultrasound controller and a pulse pattern generating circuitry in communication with the main stimulator controller and ultrasound controller, wherein the main stimulator controller and ultrasound controller are configured to control said pulse pattern generating circuitry to:

automatically generate, for each burst period of a plurality of burst periods, a first pattern of electrical stimulation pulses for transmission through a first pair of electrodes to the agonist muscle, wherein the first pattern is generated:

(i) at a constant first current amplitude level for a period sufficient to initiate contraction of the agonist muscle, and

(ii) at a constant second current amplitude level, less than the first current amplitude level, for a period sufficient to continue contraction of the agonist muscle, the second current amplitude level period consecutive to the first current amplitude level period;

automatically generate, for each burst period of the plurality of burst periods, a second pattern of electrical stimulation pulses, different from the first pattern, for transmission through the second pair of electrodes to the antagonist muscle, wherein the second pattern is generated:

(i) at a constant third current amplitude level for a period sufficient to reduce an acceleration of the limb,

(ii) at a constant fourth current amplitude level, less than the third current amplitude level, for a period sufficient to regulate a movement of the limb, the fourth intensity level period consecutive to the third current amplitude level period; and

automatically generate ultrasound treatment parameters from a user interface controller and to set up an ultrasound generator for output through an ultrasound applicator.

2. The device of claim 1 , wherein each burst period of the plurality of burst periods:

(i) represents a predetermined period of time during which electrical stimulation is applied to the agonist/antagonist muscle pair, and

(ii) is followed by a predetermined rest period during which electrical stimulation is not applied to the agonist/antagonist muscle pair.

3. The device of claim 1 , wherein each burst period of the plurality of burst periods further includes generating the first pattern of electrical stimulation pulses during a first burst period and generating the second pattern of electrical stimulation pulses during a second burst period that begins after the beginning of the first burst period and ends no later than the end of the first burst period.

4. The device of claim 1 , wherein the ultrasound treatment parameters cause the ultrasound generator to produce electrical energy at a frequency of 1 MHz.

5. The device of claim 1 , wherein the ultrasound treatment parameters cause the ultrasound generator to produce electrical energy at a frequency of approximately 3.3 MHz.

6. The device of claim 1 , further comprising the ultrasound applicator.

7. The device of claim 1 , wherein the main stimulator controller and ultrasound controller are further configured to control said pulse pattern generating circuitry to apply therapeutic treatment with both electrical stimulation and ultrasound simultaneously.

8. The device of claim 1 , wherein the second current amplitude level is 75-90% of the first current amplitude level, and wherein the fourth current amplitude level is 10-30% of the third current amplitude level.

9. The device of claim 1 , wherein the period of the second current amplitude level is at least three times greater than the period of the first current amplitude level, and wherein the period of the fourth current amplitude level is 5-15 times greater than the period of the third current amplitude level.

10. The device of claim 1 , wherein the first pattern of electrical stimulation pulses comprises a series of pulses, each of which has a pulse duration that is within the range of 20-400 μsec, and wherein the second pattern of electrical stimulation pulses comprises a series of pulses, each of which has a pulse duration that is within the range of 20-400 μsec.

11. The device of claim 1 , wherein the first pattern of electrical stimulation pulses comprises a series of pulses generated at a frequency that is within the range of 20-80 Hz, and wherein the second pattern of electrical stimulation pulses comprises a series of pulses generated at a frequency that is within the range of 20-80 Hz.

12. The device of claim 1 , wherein the electrical stimulation pulses in the first pattern of electrical stimulation pulses are generated at current amplitudes within the range of 10-150 mA, and wherein the electrical stimulation pulses in the second pattern of electrical stimulation pulses are generated at current amplitudes within the range of 10-150 mA.

13. The device of claim 1 , wherein the first pattern of electrical stimulation pulses comprises a waveform selected from the group consisting of symmetrical biphasic, asymmetrical biphasic, high volt and premodulated, and wherein the second pattern of electrical stimulation pulses comprises a waveform selected from the group consisting of symmetrical biphasic, asymmetrical biphasic, high volt and premodulated.

14. The device of claim 1 , wherein each burst period of the plurality of burst periods has a duration between 200 and 5000 msec.

15. The device of claim 1 , wherein each burst period is followed by a predetermined rest period during which electrical stimulation is not applied to the agonist/antagonist muscle pair, and each rest period has a duration at least 2-5 times the duration of the immediately preceding burst period.

Assignments (11)
SECURITY INTEREST Recorded Jan 3, 2024
From: DJO, LLC
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 066186/0659 →
MERGER Recorded May 11, 2022
From: ENCORE MEDICAL ASSET CORPORATION
To: DJO, LLC
Reel/Frame 059892/0903 →
RELEASE OF SECURITY INTEREST Recorded Mar 21, 2019
From: WELLS FARGO BANK, NATIONAL ASSOCIATION AS COLLATERAL AGENT
To: DJO, LLC; ENCORE MEDICAL, L.P.; EMPI, INC.; DJO CONSUMER, LLC; RIKCO INTERNATIONAL, LLC
Reel/Frame 048666/0700 →
RELEASE OF SECURITY INTEREST Recorded Mar 14, 2019
From: MACQUARIE US TRADING LLC AS COLLATERAL AGENT
To: DJO, LLC; ENCORE MEDICAL, L.P.; EMPI, INC.; DJO CONSUMER, LLC; RIKCO INTERNATIONAL, LLC
Reel/Frame 048604/0667 →
RELEASE OF SECURITY INTEREST Recorded Mar 14, 2019
From: THE BANK OF NEW YORK MELLON AS THIRD LIEN AGENT
To: DJO, LLC; ENCORE MEDICAL, L.P.; EMPI, INC.; DJO CONSUMER, LLC; RIKCO INTERNATIONAL, LLC
Reel/Frame 048609/0048 →
RELEASE OF SECURITY INTEREST Recorded Mar 14, 2019
From: THE BANK OF NEW YORK MELLON AS SECOND LIEN AGENT
To: DJO, LLC; ENCORE MEDICAL, L.P.; EMPI, INC.; DJO CONSUMER, LLC; RIKCO INTERNATIONAL, LLC
Reel/Frame 050129/0286 →
THIRD LIEN PATENT SECURITY AGREEMENT Recorded May 17, 2017
From: DJO, LLC; EMPI, INC.; DJO CONSUMER, LLC; ENCORE MEDICAL, L.P.; RIKCO INTERNATIONAL, LLC
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 042488/0915 →
SECOND LIEN PATENT SECURITY AGREEMENT Recorded May 17, 2017
From: DJO, LLC; EMPI, INC.; DJO CONSUMER, LLC; ENCORE MEDICAL, L.P.; RIKCO INTERNATIONAL, LLC
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 042488/0835 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2017
From: WIJTING, YORICK; POHL, JEFFREY K.
To: ENCORE MEDICAL ASSET CORPORATION
Reel/Frame 042162/0873 →
PATENT SECURITY AGREEMENT-ABL Recorded Apr 18, 2017
From: DJO, LLC; EMPI, INC.; DJO CONSUMER, LLC; ENCORE MEDICAL, L.P.; RIKCO INTERNATIONAL, LLC
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 042277/0799 →
PATENT SECURITY AGREEMENT-TL Recorded Apr 18, 2017
From: DJO, LLC; EMPI, INC.; DJO CONSUMER, LLC; ENCORE MEDICAL, L.P.; RIKCO INTERNATIONAL, LLC
To: MACQUARIE US TRADING LLC, AS COLLATERAL AGENT
Reel/Frame 042276/0208 →
Continuity (3)
Division 14144256 · Dec 30, 2013
Continuation 11706455 · Feb 13, 2007
Related Publication 20160346540A1 · Dec 1, 2016